Showering effectiveness for human hair decontamination of the nerve agent VX

Chemico-biological Interactions
D JosseCatherine Cruz

Abstract

In this work, our goals were to establish whether hair decontamination by showering one hour post-exposure to the highly toxic organophosphate nerve agent VX was effective, whether it required the addition of a detergent to water and, if it could be improved by using the adsorbent Fuller's Earth (FE) or the Reactive Skin Decontamination Lotion (RSDL) 30 min prior to showering. Hair exposure to VX and decontamination was performed by using an in vitro model. Hair showering led to 72% reduction of contamination. Addition of detergent to water slightly increased the decontamination effectiveness. Hair treatment with FE or RSDL improved the decontamination rate. Combination of FE use and showering, which yielded a decontamination factor of 41, was demonstrated to be the most effective hair decontamination procedure. Hair wiping after showering was shown to contribute to hair decontamination. Altogether, our results highlighted the importance of considering hair decontamination as an important part of body surface decontamination protocols.

References

Aug 1, 1996·Therapeutic Drug Monitoring·E J Cone
Jul 11, 1998·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·T OkumuraS Hinohara
Jun 28, 2005·Toxicology and Applied Pharmacology·T OkumuraK Suzuki
Aug 5, 2005·Journal of Forensic Sciences·Jimmie C OxleySuvarna Marimganti
Sep 28, 2005·The Journal of Investigative Dermatology·Ylva Y GramsJoke A Bouwstra
Jul 13, 2006·Cutaneous and Ocular Toxicology·Alan H Hall, Howard I Maibach
May 20, 2008·Applied and Environmental Microbiology·Pierre WattiauHein Imberechts
Jul 25, 2008·Human & Experimental Toxicology·S BjarnasonT W Sawyer
Jul 19, 2011·Toxicology in Vitro : an International Journal Published in Association with BIBRA·P RollandD Josse
Aug 11, 2011·Journal of Pharmacy & Bioallied Sciences·Vinod KumarRakesh Kumar Sharma
Oct 18, 2011·Disaster Medicine and Public Health Preparedness·Thomas K Zink
May 3, 2012·Health Physics·Maarit Muikku, Tarja Heikkinen
Aug 29, 2012·Toxicology in Vitro : an International Journal Published in Association with BIBRA·P RollandS Briançon
Sep 12, 2012·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Jan MisikKamil Kuca
Oct 23, 2012·Chemico-biological Interactions·Marloes J A JoosenDaan Noort
May 30, 2013·American Journal of Disaster Medicine·David J BakerPierre A Carli
Jan 15, 2014·Toxicology in Vitro : an International Journal Published in Association with BIBRA·H MatarR P Chilcott

❮ Previous
Next ❯

Citations

Jan 10, 2018·Journal of Applied Toxicology : JAT·Yachao CaoHoward Maibach
Jun 27, 2019·Toxicological Sciences : an Official Journal of the Society of Toxicology·Hazem MatarRobert P Chilcott
Apr 4, 2021·International Journal of Environmental Research and Public Health·Samuel CollinsRichard Amlôt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.